Inventor · disambiguated record
Ming Wang
Also filed as: WANG MING · WANG MING-DE
23 granted patents·14 pending applications·163 citations·filing 1999–2016
95Inventor score
Files withBAYER PHARMACEUTICALS CORP11MERCK SHARP & DOHME8LOWE DEREK B4MILLER SCOTT3BAYER HEALTHCARE LLC2
Top patents by PatentIndex Score
37 records- 0186US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 0286US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 0385US7678804B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER HEALTHCARE LLC·Filed 2005·Granted Mar 16, 2010·4 cites·11 claims
- 0484US6911443B2Imidazopyrimidine derivatives and triazolopyrimidine derivativesBAYER AG·Filed 2001·Granted Jun 28, 2005·32 cites·7 claims
- 0583US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 0682US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 0779US8114860B2GABA-steroid antagonists and their use for the treatment of CNS disordersBACKSTROM TORBJORN·Filed 2005·Granted Feb 14, 2012·8 cites·3 claims
- 0878US10450335B2Antiviral oxime phosphoramide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Oct 22, 2019·3 cites·26 claims
- 0978US9751881B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 1076US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 1175US9499534B2Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 22, 2016·1 cites·14 claims
- 1272US8119619B2Pregnane steroids and their use in the treatment of CNS disordersBAECKSTROEM TORBJOERN·Filed 2011·Granted Feb 21, 2012·3 cites·17 claims
- 1370US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 1468US6455516B1Method and compounds for use in the treatment of steroid induced states of the central nervous systemFiled 1999·Granted Sep 24, 2002·27 cites·4 claims
- 1567US8541618B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Sep 24, 2013·1 cites·44 claims
- 1667US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 1766US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 1859US2011065129A1Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2009·Application pending·0 cites
- 1959US2009047687A1Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of PreparationLOWE DEREK B·Filed 2008·Application pending·0 cites
- 2058US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 2153US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 2252US8552203B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Oct 8, 2013·0 cites·11 claims
- 2352US2008269265A1Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl UreasMILLER SCOTT·Filed 2008·Application pending·0 cites
- 2452US2012270878A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2012·Application pending·0 cites
- 2550US9815796B2Pyrimidone carboxamide compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 14, 2017·0 cites·21 claims
- 2645US8372824B2GABA-steroid antagonists and their use for the treatment of CNS disordersUMECRINE AB·Filed 2012·Granted Feb 12, 2013·0 cites·6 claims
- 2745US7960367B2Pregnane steroids and their use in the treatment of CNS disordersUMECRINE AB·Filed 2002·Granted Jun 14, 2011·0 cites·19 claims
- 2843US2011098301A1Pyrimidine Derivatives for Treatment of Hyperproliferative DisordersBAYER HEALTHCARE LLC·Filed 2006·Application pending·0 cites
- 2943US2009258888A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3043US2009286785A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3142US10472344B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 12, 2019·0 cites·10 claims
- 3241US10357481B2Substituted triazolo bicyclic compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 23, 2019·0 cites·8 claims
- 3337US2003229072A1Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agentsFiled 2001·Application pending·0 cites
- 3436US10065945B2Isoquinoline derivatives as MGAT2 inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 4, 2018·0 cites·14 claims
- 3533US2017247336A1Substituted pyrimidines as inhibitors of hif prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 3632US2017240513A1Substituted pyrimidines as inhibitors of hif prolyl hydroxylaseUJJAINWALLA FEZ·Filed 2015·Application pending·0 cites
- 3731US2017240511A1Substituted pyridine inhibitors of hif prolyl hydroxylaseUJJAINWALLA FEZ·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →